Biondi, B., & Wartofsky, L. (2014). Treatment with thyroid hormone. Endocrine Reviews, 35(3), 433–512. https://doi.org/10.1210/er.2013-1083

Çelik, Ö., & Köse, M. F. (2021). An overview of polycystic ovary syndrome in aging women. Journal of the Turkish German Gynecological Association, 22(4), 326–333. https://doi.org/10.4274/jtgga.galenos.2021.2021.0077

Chen, W. Y., Manson, J. E., Hankinson, S. E., Rosner, B., Holmes, M. D., Willett, W. C., & Colditz, G. A. (2006). Unopposed estrogen therapy and the risk of invasive breast cancer. Archives of Internal Medicine, 166(9), 1027–1032. https://doi.org/10.1001/archinte.166.9.1027

Chmouliovsky, L., Habicht, F., James, R. W., Lehmann, T., Campana, A., & Golay, A. (1999). Beneficial effect of hormone replacement therapy on weight loss in obese menopausal women. Maturitas, 32(3), 147–153. https://doi.org/10.1016/s0378-5122(99)00037-7

Cirigliano, M. (2007). Bioidentical hormone therapy: a review of the evidence. Journal of Women's Health, 16(5), 600–631. https://doi.org/10.1089/jwh.2006.0311

de Lignieres, B. (1999). Endometrial hyperplasia. Risks, recognition and the search for a safe hormone replacement regimen. The Journal of Reproductive Medicine, 44(2 Suppl), 191–196.

Duntas, L. H., & Brenta, G. (2018). A renewed focus on the association between thyroid hormones and lipid metabolism. Frontiers in Endocrinology, 9, 511. https://doi.org/10.3389/fendo.2018.00511

Feld, S., & Dickey, R. A. (2001). An association between varying degrees of hypothyroidism and hypercholesterolemia in women: The thyroid-cholesterol connection. Preventive Cardiology, 4(4), 179–182. https://doi.org/10.1111/j.1520-037x.2001.00541

Figueiredo, M. G., Gagliano-Jucá, T., & Basaria, S. (2022). Testosterone therapy with subcutaneous injections: A safe, practical, and reasonable option. The Journal of Clinical Endocrinology and Metabolism, 107(3), 614–626. https://doi.org/10.1210/clinem/dgab772

Finkelstein, J. S., Lee, H., Burnett-Bowie, S. A., Pallais, J. C., Yu, E. W., Borges, L. F., Jones, B. F., Barry, C. V., Wulczyn, K. E., Thomas, B. J., & Leder, B. Z. (2013). Gonadal steroids and body composition, strength, and sexual function in men. New England Journal of Medicine, 369(11), 1011–1022. https://doi.org/10.1056/NEJMoa1206168

Fleischmann, K. E. (2009). Perimenopausal changes in cardiac risk factors. Journal of the American College of Cardiology, 15, 22.

Gerhard, M., Walsh, B. W., Tawakol, A., Haley, E. A., Creager, S. J., Seely, E. W., Ganz, P., & Creager, M. A. (1998). Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women. Circulation, 98(12), 1158–1163. https://doi.org/10.1161/01.cir.98.12.1158

Giallauria, F., Orio, F., Palomba, S., Lombardi, G., Colao, A., & Vigorito, C. (2008). Cardiovascular risk in women with polycystic ovary syndrome. Journal of Cardiovascular Medicine, 9(10), 987–992. https://doi.org/10.2459/JCM.0b013e32830b58d4

Gizard, F., Robillard, R., Gervois, P., Faucompré, A., Révillion, F., Peyrat, J. P., Hum, W. D., & Staels, B. (2005). Progesterone inhibits human breast cancer cell growth through transcriptional upregulation of the cyclin-dependent kinase inhibitor p27Kip1 gene. FEBS Letters, 579(25), 5535–5541. https://doi.org/10.1016/j.febslet.2005.08.084

Hedland, A. H., Taylor, P., Premawardhana, L., Stedman, M., & Dayan, C. (2024). Natural desiccated thyroid for the treatment of hypothyroidism? Frontiers in Endocrinology, 14, 1309159. https://doi.org/10.3389/fendo.2023.1309159

Henderson, V. W., Benke, K. S., Green, R. C., Cupples, L. A., Farrer, L. A., & MIRAGE Study Group. (2005). Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age. Journal of Neurology, Neurosurgery, and Psychiatry, 76(1), 103–105. https://doi.org/10.1136/jnnp.2003.024927

Hodis, H. N., & Mack, W. J. (2008). In perspective: Estrogen therapy proves to safely and effectively reduce total mortality and coronary heart disease in recently postmenopausal women. Menopause Management, 17(2), 27–32.

Karim, R., Mack, W. J., Lobo, R. A., Hwang, J., Liu, C. R., Liu, C. H., Sevanian, A., & Hodis, H. N. (2005). Determinants of the effect of estrogen on the progression of subclinical atherosclerosis: Estrogen in the Prevention of Atherosclerosis Trial. Menopause, 12(4), 366–373. https://doi.org/10.1097/01.GME.0000153934.76086.A4

Kapoor, D., Goodwin, E., Channer, K. S., & Jones, T. H. (2006). Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. European Journal of Endocrinology, 154(6), 899–906. https://doi.org/10.1530/eje.1.02166

Kolhe, J. V., Chhipa, A. S., Butani, S., Chavda, V., & Patel, S. S. (2022). PCOS and depression: common links and potential targets. Reproductive Sciences, 29(11), 3106–3123. https://doi.org/10.1007/s43032-021-00765-2

Kung, A. W., & Yeung, S. S. (1996). Prevention of bone loss induced by thyroxine suppressive therapy in postmenopausal women: The effect of calcium and calcitonin. The Journal of Clinical Endocrinology and Metabolism, 81(3), 1232–1236. https://doi.org/10.1210/jcem.81.3.8772604

L'hermite, M., Simoncini, T., Fuller, S., & Genazzani, A. R. (2008). Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review. Maturitas, 60(3-4), 185–201. https://doi.org/10.1016/j.maturitas.2008.07.007

Malkin, C. J., Pugh, P. J., Jones, R. D., Kapoor, D., Channer, K. S., & Jones, T. H. (2004). The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. The Journal of Clinical Endocrinology and Metabolism, 89(7), 3313–3318. https://doi.org/10.1210/jc.2003-031069

Mayes, J. S., & Watson, G. H. (2004). Direct effects of sex steroid hormones on adipose tissues and obesity. Obesity Reviews, 5(4), 197–216. https://doi.org/10.1111/j.1467-789X.2004.00152.x

Mikkola, T. S., Tuomikoski, P., Lyytinen, H., Korhonen, P., Hoti, F., Vattulainen, P., Gissler, M., & Ylikorkala, O. (2015). Estradiol-based postmenopausal hormone therapy and risk of cardiovascular and all-cause mortality. Menopause, 22(9), 976–983. https://doi.org/10.1097/GME.0000000000000450

Miller, K. E. (2005). Osteoporosis prevention in postmenopausal women. American Family Physician, 72(5), 926–928.

Mohamad, N. V., Wong, S. K., Wan Hasan, W. N., Jolly, J. J., Nur-Farhana, M. F., Ima-Nirwana, S., & Chin, K. Y. (2019). The relationship between circulating testosterone and inflammatory cytokines in men. The Aging Male, 22(2), 129–140.

Moe, B. G., Vereide, A. B., Orbo, A., & Sager, G. (2009). High concentrations of progesterone and mifepristone mutually reinforce cell cycle retardation and induction of apoptosis. Anticancer Research, 29(4), 1053–1058.

Nandi, A., Chen, Z., Patel, R., & Poretsky, L. (2014). Polycystic ovary syndrome. Endocrinology and Metabolism Clinics of North America, 43(1), 123–147. https://doi.org/10.1016/j.ecl.2013.10.003

Oiwoh, S. O., Enitan, A. O., Adegbosin, O. T., Akinboro, A. O., & Onayemi, E. O. (2024). Androgenetic alopecia: A review. The Nigerian Postgraduate Medical Journal, 31(2), 85–92. https://doi.org/10.4103/npmj.npmj_47_24

Paganini-Hill, A., Corrada, M. M., & Kawas, C. H. (2018). Increased longevity in older users of postmenopausal estrogen therapy: The Leisure World Cohort Study. Menopause, 25(11), 1256–1261. https://doi.org/10.1097/GME.0000000000001227

Pepping, J. (2000). DHEA: Dehydroepiandrosterone. American Journal of Health-System Pharmacy, 57(22), 2048–2056. https://doi.org/10.1093/ajhp/57.22.2048

Purnell, J. Q., Bland, L. B., Garzotto, M., Lemmon, D., Wersinger, E. M., Ryan, C. W., Brunzell, J. D., & Beer, T. M. (2006). Effects of transdermal estrogen on levels of lipids, lipase activity, and inflammatory markers in men with prostate cancer. Journal of Lipid Research, 47(2), 349–355. https://doi.org/10.1194/jlr.M500276-JLR200

Richardson, M. R. (2003). Current perspectives in polycystic ovary syndrome. American Family Physician, 68(4), 697–704.

Rudnicka, E., Suchta, K., Grymowicz, M., Calik-Ksepka, A., Smolarczyk, K., Duszewska, A. M., Smolarczyk, R., & Meczekalski, B. (2021). Chronic low-grade inflammation in pathogenesis of PCOS. International Journal of Molecular Sciences, 22(7), 3789. https://doi.org/10.3390/ijms22073789

Savage, L., & Widener, A. (2008). Sex hormones unrelated to prostate cancer risk. JNCI, 100(3), 157.

Scherr, D. S., & Pitts, W. R., Jr. (2003). The nonsteroidal effects of diethylstilbestrol: The rationale for androgen deprivation therapy without estrogen deprivation in the treatment of prostate cancer. The Journal of Urology, 170(5), 1703–1708. https://doi.org/10.1097/01.ju.0000077558.48257.3d

Schumacher, M., Guennoun, R., Ghoumari, A., Massaad, C., Robert, F., El-Etr, M., Akwa, Y., Rajkowski, K., & Baulieu, E. E. (2007). Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system. Endocrine Reviews, 28(4), 387–439. https://doi.org/10.1210/er.2006-0050

Severi, G., Morris, H. A., MacInnis, R. J., English, D. R., Tilley, W., Hopper, J. L., Boyle, P., & Giles, G. G. (2006). Circulating steroid hormones and the risk of prostate cancer. Cancer Epidemiology, Biomarkers & Prevention, 15(1), 86–91. https://doi.org/10.1158/1055-9965.EPI-05-0633

Shabsigh, R., Crawford, E. D., Nehra, A., & Slawin, K. M. (2009). Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review. International Journal of Impotence Research, 21(1), 9–23. https://doi.org/10.1038/ijir.2008.31

Smith, N. L., Blondon, M., Wiggins, K. L., Harrington, L. B., van Hylckama Vlieg, A., Floyd, J. S., Hwang, M., Bis, J. C., McKnight, B., Rice, K. M., Lumley, T., Rosendaal, F. R., Heckbert, S. R., & Psaty, B. M. (2014). Lower risk of cardiovascular events in postmenopausal women taking oral estradiol compared with oral conjugated equine estrogens. JAMA Internal Medicine, 174(1), 25–31. https://doi.org/10.1001/jamainternmed.2013.11074

Yu, S., Lee, M., Shin, S., & Park, J. (2001). Apoptosis induced by progesterone in human ovarian cancer cell line SNU-840. Journal of Cellular Biochemistry, 82(3), 445–451. https://doi.org/10.1002/jcb.1171

Ye, X., & Li, T. (2024). Effects of hysteroscopic surgery combined with progesterone therapy on fertility and prognosis in patients with early endometrial cancer and atypical endometrial hyperplasia or endometrial intraepithelial neoplasia: a meta-analysis. Archives of Gynecology and Obstetrics, 309(1), 259–268. https://doi.org/10.1007/s00404-023-07173-8